The ADAs consensus since 2018 explicitly states: Consider a GLP-1 receptor agonist before insulin in most patients who need injectable therapy due to their efficacy, lower hypoglycemia risk, and weight loss advantage ( [10] ) ( [11] )
If you take it in the morning, wait at least an hour before having any food or other medications, especially since the GLP-1 will slow down your stomach's ability to clear that space
Anh GF, Caperuto LC, Pereira-Da-Silva M, Souza LC, Hirata AE, Velloso LA, et al
Semaglutide and tirzepatide bind to GLP-1 receptors with high affinity, triggering satiety sensations that persist for hours after a single injection
Interpretation of the cardiovascular actions of native GLP-1 requires consideration that carboxy- terminal fragments, such as GLP-1(936) and GLP-1(2836), the latter generated from neutral endopeptidase-mediated proteolytic cleavage, retain biological activity in the cardiovascular system through mechanisms independent of the canonical GLP-1R
If used, it should follow hormonal evaluation, metabolic lab review, and a lean mass preservation strategy